ask="3.25"
ask_size="1500"
average_daily_volume="157855"
bid="2.01"
bid_size="100"
book_value="0.74"
change="+0.01"
change_from_200_day_moving_average="0.28"
change_from_50_day_moving_average="0.05"
change_from_52_week_high="-0.92"
change_From_52_week_low="1.44"
change_in_percent="+0.35%"
close="2.90"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.11"
ebitda="-30.33M"
eps_estimate_current_year="-1.14"
eps_estimate_next_quarter="-0.23"
eps_estimate_next_year="-0.96"
ex_dividend_date="N/A"
float_shares="21613000"
high="3.03"
high_52_weeks="3.82"
last_trade_date="1/25/2017"
last_trade_price="2.90"
last_trade_size="135"
last_trade_time="4:00pm"
low="2.85"
low_52_weeks="1.46"
market_capitalization="99.03M"
moving_average_200_day="2.62"
moving_average_50_day="2.85"
name="Fate Therapeutics
Inc."
notes="N/A"
one_year_target_price="5.83"
open="2.89"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+10.89%"
percent_change_from_50_day_moving_average="+1.74%"
percent_change_from_52_week_high="-24.08%"
percent_change_from_52_week_low="+98.63%"
previous_close="2.89"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.89"
price_per_sales="22.17"
revenue="4.45M"
shares_outstanding="34148000"
short_ratio="3.18"
stock_exchange="NGM"
symbol="FATE"
volume="124089"
weeks_range_52="1.46 - 3.82"
